 |
 Video: What is a Stock Split?
|
|
|
| OptiNose is a pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat and allergy specialists. Co.'s commercial product, XHANCE® (fluticasone propionate) nasal spray is a therapeutic utilizing its proprietary Exhalation Delivery System™ (EDS®) for the treatment of chronic rhinosinusitis with nasal polyps and. Co.'s solutions also include EDS, which enables the development of drug-device combination products intended for self-administration. Co. has developed both a liquid delivery EDS and a powder delivery EDS utilizing natural functional behaviors of the upper nasal airways intended to provide drug deposition. According to our OPTN split history records, OptiNose has had 2 splits. | |
|
OptiNose (OPTN) has 2 splits in our OPTN split history database. The first split for OPTN took place on May 02, 2002. This was a 5 for 4 split, meaning for each 4 shares of OPTN owned pre-split, the shareholder now owned 5 shares. For example, a 1000 share position pre-split, became a 1250 share position following the split. OPTN's second split took place on April 01, 2005. This was a 3 for 2 split, meaning for each 2 shares of OPTN owned pre-split, the shareholder now owned 3 shares. For example, a 1250 share position pre-split, became a 1875 share position following the split.
When a company such as OptiNose splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the OPTN split history from start to finish, an original position size of 1000 shares would have turned into 1875 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into OptiNose shares, starting with a $10,000 purchase of OPTN, presented on a split-history-adjusted basis factoring in the complete OPTN split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/16/2017 |
|
| End date: |
04/18/2024 |
|
| Start price/share: |
$19.61 |
|
| End price/share: |
$0.93 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-95.27% |
|
| Average Annual Total Return: |
-37.42% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$473.02 |
|
| Years: |
6.51 |
|
|
|
| Date |
Ratio |
| 05/02/2002 | 5 for 4 | | 04/01/2005 | 3 for 2 |
|
|
Free OPTN Email Alerts:
